388 related articles for article (PubMed ID: 29083972)
21. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β
Buhl R; Heaney LG; Loefroth E; Larbig M; Kostikas K; Conti V; Cao H
Respir Med; 2020 Feb; 162():105859. PubMed ID: 31916534
[TBL] [Abstract][Full Text] [Related]
22. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
23. Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma.
Villa-Roel C; Borgundvaag B; Majumdar SR; Emond M; Campbell S; Sivilotti M; Abu-Laban RB; Stiell IG; Aaron SD; Senthilselvan A; Rowe BH;
J Asthma; 2019 Sep; 56(9):985-994. PubMed ID: 30311821
[No Abstract] [Full Text] [Related]
24. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
25. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
26. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
[TBL] [Abstract][Full Text] [Related]
27. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
Stanford RH; Blanchette CM; Roberts MH; Petersen H; Fuhlbrigge AL
Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
[TBL] [Abstract][Full Text] [Related]
28. Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio.
Luskin AT; Antonova EN; Broder MS; Chang E; Raimundo K; Solari PG
J Manag Care Spec Pharm; 2017 Nov; 23(11):1117-1124. PubMed ID: 29083971
[TBL] [Abstract][Full Text] [Related]
29. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study.
Thomas M; Murray-Thomas T; Fan T; Williams T; Taylor S
BMC Pulm Med; 2010 May; 10():29. PubMed ID: 20470409
[TBL] [Abstract][Full Text] [Related]
30. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
[TBL] [Abstract][Full Text] [Related]
31. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
Palli SR; Zhou S; Shaikh A; Willey VJ
J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
[No Abstract] [Full Text] [Related]
32. Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.
Jain R; Fu AC; Lim J; Wang C; Elder J; Sander SD; Tan H
J Manag Care Spec Pharm; 2018 Jan; 24(1):73-82. PubMed ID: 29290177
[TBL] [Abstract][Full Text] [Related]
33. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
Kew KM; Quinn M; Quon BS; Ducharme FM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007524. PubMed ID: 27272563
[TBL] [Abstract][Full Text] [Related]
34. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
35. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
[TBL] [Abstract][Full Text] [Related]
36. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
Chung KF; Caramori G; Adcock IM
Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
[TBL] [Abstract][Full Text] [Related]
37. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
Cates CJ; Karner C
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
[TBL] [Abstract][Full Text] [Related]
38. Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States.
Averell CM; Laliberté F; Germain G; Duh MS; Rousculp MD; MacKnight SD; Slade DJ
Ther Adv Respir Dis; 2022; 16():17534666221116997. PubMed ID: 36036456
[TBL] [Abstract][Full Text] [Related]
39. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
40. The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
FitzGerald JM; Arnetorp S; Smare C; Gibson D; Coulton K; Hounsell K; Golam S; Sadatsafavi M
Respir Med; 2020 Sep; 171():106079. PubMed ID: 32917353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
